Abstract
Aptamer advantages: Cell-specific delivery of the anticancer drug cisplatin through a nucleolinaptamer- conjugated, cisplatin-encapsulating liposome delivery system is described. Calcein was incorporated into the target MCF-7 cells (see top image) but not into LNCaP cells (see bottom image). More importantly, the extent of delivery can be controlled by using a complementary DNA of the aptamer as an antidote.
Original language | English (US) |
---|---|
Pages (from-to) | 6494-6498 |
Number of pages | 5 |
Journal | Angewandte Chemie - International Edition |
Volume | 48 |
Issue number | 35 |
DOIs | |
State | Published - 2009 |
Keywords
- Aptamers
- Cisplatin
- Drug delivery
- Liposomes
ASJC Scopus subject areas
- General Chemistry
- Catalysis
- General Medicine